Abbott Laboratories reported Q4 2025 sales of $11.46 billion, an increase of 4.4% from the previous year but falling short of analyst projections by approximately 3%. The adjusted EPS was $1.50, ...

As earnings season nears, Seeking Alpha highlights the mid-cap financial stocks showing the weakest EPS revisions. Each ...

Intel Corporation faces soft Q1 guidance, margin compression, and a stretched 80x–91.6x forward PE as execution risks persist. Read why INTC stock is a sell.

Q1 2025 Management View Jennifer Sherman, President and CEO, highlighted that Federal Signal achieved record-high Q1 consolidated net sales, adjusted EPS, and adjusted EBITDA margin. She attributed ...

Wall Street is in the late innings of earnings season, and results have been solid. Morgan Stanley analysts believe two datapoints in particular indicate further strength ahead for stocks. The bank's ...